20 related articles for article (PubMed ID: 1373879)
1. ERK1b, a 46-kDa ERK isoform that is differentially regulated by MEK.
Yung Y; Yao Z; Hanoch T; Seger R
Cell Biol Int; 2022 Jul; 46(7):1021-1035. PubMed ID: 35332606
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive analysis of the genome transcriptome and proteome landscapes of three tumor cell lines.
Akan P; Alexeyenko A; Costea PI; Hedberg L; Solnestam BW; Lundin S; Hällman J; Lundberg E; Uhlén M; Lundeberg J
Genome Med; 2012; 4(11):86. PubMed ID: 23158748
[TBL] [Abstract][Full Text] [Related]
3. Nucleosomal structures of c-myc promoters with transcriptionally engaged RNA polymerase II.
Albert T; Mautner J; Funk JO; Hörtnagel K; Pullner A; Eick D
Mol Cell Biol; 1997 Aug; 17(8):4363-71. PubMed ID: 9234694
[TBL] [Abstract][Full Text] [Related]
4. Microsatellite instability in IVS3 of murine c-fes gene: tumor-associated rearrangement and mammalian divergence.
Volpi L; Beghini A; Rossi D; Larizza L
Mamm Genome; 1996 Sep; 7(9):682-5. PubMed ID: 8703122
[TBL] [Abstract][Full Text] [Related]
5. The myeloid-cell-specific c-fes promoter is regulated by Sp1, PU.1, and a novel transcription factor.
Heydemann A; Juang G; Hennessy K; Parmacek MS; Simon MC
Mol Cell Biol; 1996 Apr; 16(4):1676-86. PubMed ID: 8657143
[TBL] [Abstract][Full Text] [Related]
6. Identification of two enhancer elements downstream of the human c-myc gene.
Mautner J; Joos S; Werner T; Eick D; Bornkamm GW; Polack A
Nucleic Acids Res; 1995 Jan; 23(1):72-80. PubMed ID: 7870592
[TBL] [Abstract][Full Text] [Related]
7. c-met is amplified but not mutated in a cell line with an activated met tyrosine kinase.
Ponzetto C; Giordano S; Peverali F; Della Valle G; Abate ML; Vaula G; Comoglio PM
Oncogene; 1991 Apr; 6(4):553-9. PubMed ID: 1674365
[TBL] [Abstract][Full Text] [Related]
8. DNA binding specificities of Spi-1/PU.1 and Spi-B transcription factors and identification of a Spi-1/Spi-B binding site in the c-fes/c-fps promoter.
Ray-Gallet D; Mao C; Tavitian A; Moreau-Gachelin F
Oncogene; 1995 Jul; 11(2):303-13. PubMed ID: 7624145
[TBL] [Abstract][Full Text] [Related]
9. Isolation and characterization of four alternate c-erbB3 transcripts expressed in ovarian carcinoma-derived cell lines and normal human tissues.
Lee H; Maihle NJ
Oncogene; 1998 Jun; 16(25):3243-52. PubMed ID: 9681822
[TBL] [Abstract][Full Text] [Related]
10. Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product.
Furitsu T; Tsujimura T; Tono T; Ikeda H; Kitayama H; Koshimizu U; Sugahara H; Butterfield JH; Ashman LK; Kanayama Y
J Clin Invest; 1993 Oct; 92(4):1736-44. PubMed ID: 7691885
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of c-fos in a human pre-B cell acute lymphocytic leukemia derived cell line, SMS-SB.
Tsai LH; Nanu L; Smith RG; Ozanne B
Oncogene; 1991 Jan; 6(1):81-8. PubMed ID: 1704120
[TBL] [Abstract][Full Text] [Related]
12. Expression of truncated transcripts of the proto-oncogene c-fps/fes in human lymphoma and lymphoid leukemia cell lines.
Jücker M; Roebroek AJ; Mautner J; Koch K; Eick D; Diehl V; Van de Ven WJ; Tesch H
Oncogene; 1992 May; 7(5):943-52. PubMed ID: 1373879
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
